future glp 1 drugs Didn't take much for the time magazine to do a flip! From “The big promise” to “A metabolic whiplash” A new study came out yesterday that showed that stopping GLP-1 for The expanding landscape of GLP-1
Description
Wiviott SD, Raz I, Bonaca MP, et al
Novo Nordisk Earnings: Shares Remain Overvalued Despite Our $100 Billion GLP-1 Market Forecast
But insulin dose reduction needs to be done carefully and gradually, with close CGM monitoring, to avoid either hypoglycemia (from too much insulin relative to your new needs) or hyperglycemia (from reducing too aggressively)
Notably, a study by Finan et al
doi: 10.3390/ijms18112493 13 NguyenTTTaQTHNguyenTKONguyenTTDGiauVV
